Please provide your email address to receive an email when new articles are posted on . Etripamil, a novel fast-acting calcium channel blocker administered via nasal spray, was not superior to placebo ...
Etripamil nasal spray (Milestone Pharmaceuticals) continues to show promise as a way for patients to treat their own paroxysmal supraventricular tachycardia (PSVT) without the need for an emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results